Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
940.2 INR | -1.24% | -2.63% | +23.81% |
Sales 2024 * | 63.38B 761M | Sales 2025 * | 70.38B 845M | Capitalization | 185B 2.22B |
---|---|---|---|---|---|
Net income 2024 * | 5.92B 71.07M | Net income 2025 * | 7.03B 84.43M | EV / Sales 2024 * | 2.96 x |
Net Debt 2024 * | 2.62B 31.43M | Net cash position 2025 * | 457M 5.49M | EV / Sales 2025 * | 2.62 x |
P/E ratio 2024 * |
31.1
x | P/E ratio 2025 * |
26.2
x | Employees | 14,593 |
Yield 2024 * |
0.95% | Yield 2025 * |
1.07% | Free-Float | 29.28% |
Latest transcript on Alembic Pharmaceuticals Limited
1 day | -1.24% | ||
1 week | -2.63% | ||
Current month | -4.52% | ||
1 month | -2.82% | ||
3 months | -0.29% | ||
6 months | +24.69% | ||
Current year | +23.81% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Manisha Saraf
CMP | Compliance Officer | - | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Director/Board Member | 56 | 15-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | +0.24% | - | |
0.00% | 34 M€ | +2.38% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 940.2 | -1.24% | 57 145 |
24-04-22 | 952.1 | +1.47% | 61,662 |
24-04-19 | 938.4 | +0.78% | 69,069 |
24-04-18 | 931 | -3.58% | 174,076 |
24-04-16 | 965.6 | -0.30% | 53,601 |
Delayed Quote NSE India S.E., April 23, 2024 at 07:51 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.81% | 2.24B | |
+27.01% | 659B | |
+27.68% | 557B | |
-4.82% | 359B | |
+16.84% | 322B | |
+9.50% | 297B | |
+6.11% | 215B | |
+5.27% | 210B | |
-6.09% | 200B | |
-8.40% | 149B |
- Stock Market
- Equities
- APLLTD Stock